Search results for

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

When RFK Jr. announced he would cut funds from Gavi, the Vaccine Alliance, he cited "vaccine safety," referring to a 2017 study from Guinea-Bissau. We asked vaccine researchers to assess the study.

Supervisor Terra Lawson-Remer created the Immigrant Legal Defense Program in 2021. It’s now helping thousands of people navigate their cases in local immigration courts.

The administration argues the men's home countries won't take them — but lawyers say getting sent to a country like South Sudan could lead to more persecution.

The State Department's decision to impose sanctions on Francesca Albanese, the U.N. special rapporteur for the West Bank and Gaza, follows an unsuccessful campaign to force her removal.

The health care conglomerate is facing mounting financial problems – and ongoing consumer anger over high costs and denied claims.

A new study shows Medicaid expansion under the Affordable Care Act reduced the risk of death, just as lawmakers debate slashing the program by $800 billion.

In places like Antarctica, small things can make a difference. Scientists are finding that penguin waste is helping form clouds, which could be offsetting the effects of climate change.

The health care giant's shares are down more than 50% in the last month. That's hurting the powerful U.S. stock-market index.

Trump promised a new "golden age" for the U.S. But his first 100 days in office have left the economy looking tarnished, with data showing the economy contracted in the first three months of the year.